Northern Trust’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.82M | Buy |
1,801,200
+73,691
| +4% | +$413K | ﹤0.01% | 2092 |
|
|
2025
Q4 | $12.1M | Sell |
1,727,509
-90,402
| -5% | -$708K | ﹤0.01% | 1983 |
|
|
2025
Q3 | $14.1M | Buy |
1,817,911
+705
| +0% | +$5.5K | ﹤0.01% | 1907 |
|
|
2025
Q2 | $15.8M | Buy |
1,817,206
+205,186
| +13% | +$1.49M | ﹤0.01% | 1798 |
|
|
2025
Q1 | $12.8M | Sell |
1,612,020
-67,362
| -4% | -$681K | ﹤0.01% | 1896 |
|
|
2024
Q4 | $15.3M | Buy |
1,679,382
+161,875
| +11% | +$1.56M | ﹤0.01% | 1865 |
|
|
2024
Q3 | $13.9M | Buy |
1,517,507
+692,088
| +84% | +$5.73M | ﹤0.01% | 1865 |
|
|
2024
Q2 | $8.07M | Buy |
825,419
+69,507
| +9% | +$848K | ﹤0.01% | 2114 |
|
|
2024
Q1 | $11.4M | Sell |
755,912
-34,735
| -4% | -$630K | ﹤0.01% | 1958 |
|
|
2023
Q4 | $17M | Buy |
790,647
+52,836
| +7% | +$975K | ﹤0.01% | 1732 |
|
|
2023
Q3 | $13.7M | Buy |
737,811
+19,890
| +3% | +$464K | ﹤0.01% | 1792 |
|
|
2023
Q2 | $18.2M | Sell |
717,921
-4,866
| -0.7% | -$122K | ﹤0.01% | 1657 |
|
|
2023
Q1 | $18.7M | Sell |
722,787
-2,694
| -0.4% | -$72.1K | ﹤0.01% | 1601 |
|
|
2022
Q4 | $17.2M | Sell |
725,481
-205,411
| -22% | -$5.54M | ﹤0.01% | 1632 |
|
|
2022
Q3 | $23.6M | Sell |
930,892
-108,325
| -10% | -$3.8M | 0.01% | 1352 |
|
|
2022
Q2 | $34.5M | Buy |
1,039,217
+49,855
| +5% | +$2.12M | 0.01% | 1146 |
|
|
2022
Q1 | $71.4M | Buy |
989,362
+17,446
| +2% | +$1.26M | 0.01% | 807 |
|
|
2021
Q4 | $89.2M | Sell |
971,916
-28,403
| -3% | -$3.39M | 0.01% | 721 |
|
|
2021
Q3 | $127M | Buy |
1,000,319
+149,503
| +18% | +$21.8M | 0.02% | 572 |
|
|
2021
Q2 | $141M | Buy |
850,816
+73,632
| +9% | +$11.9M | 0.02% | 548 |
|
|
2021
Q1 | $141M | Sell |
777,184
-13,071
| -2% | -$3.03M | 0.03% | 540 |
|
|
2020
Q4 | $158M | Buy |
790,255
+256,689
| +48% | +$52.2M | 0.03% | 481 |
|
|
2020
Q3 | $117M | Buy |
533,566
+28,200
| +6% | +$5.97M | 0.03% | 512 |
|
|
2020
Q2 | $96.4M | Sell |
505,366
-467,765
| -48% | -$82M | 0.02% | 557 |
|
|
2020
Q1 | $151M | Sell |
973,131
-27,995
| -3% | -$3.26M | 0.04% | 362 |
|
|
2019
Q4 | $83.8M | Sell |
1,001,126
-60,015
| -6% | -$4.57M | 0.02% | 676 |
|
|
2019
Q3 | $71.9M | Buy |
1,061,141
+56,837
| +6% | +$3.74M | 0.02% | 710 |
|
|
2019
Q2 | $66.7M | Buy |
1,004,304
+76,396
| +8% | +$4.45M | 0.02% | 794 |
|
|
2019
Q1 | $51.6M | Buy |
927,908
+9,040
| +1% | +$552K | 0.01% | 944 |
|
|
2018
Q4 | $45.5M | Buy |
918,868
+19,943
| +2% | +$1.22M | 0.01% | 927 |
|
|
2018
Q3 | $77.6M | Buy |
898,925
+99,386
| +12% | +$7.08M | 0.02% | 689 |
|
|
2018
Q2 | $46.4M | Buy |
799,539
+58,189
| +8% | +$2.84M | 0.01% | 1074 |
|
|
2018
Q1 | $29.9M | Buy |
741,350
+28,743
| +4% | +$1.09M | 0.01% | 1391 |
|
|
2017
Q4 | $24.8M | Buy |
712,607
+29,651
| +4% | +$985K | 0.01% | 1546 |
|
|
2017
Q3 | $22.6M | Buy |
682,956
+5,007
| +0.7% | +$164K | 0.01% | 1620 |
|
|
2017
Q2 | $23.5M | Buy |
677,949
+333,452
| +97% | +$9.72M | 0.01% | 1554 |
|
|
2017
Q1 | $8.61M | Buy |
344,497
+67,346
| +24% | +$1.4M | ﹤0.01% | 2218 |
|
|
2016
Q4 | $4.57M | Buy |
277,151
+22,165
| +9% | +$376K | ﹤0.01% | 2599 |
|
|
2016
Q3 | $4.67M | Buy |
254,986
+25,686
| +11% | +$451K | ﹤0.01% | 2557 |
|
|
2016
Q2 | $3.67M | Buy |
229,300
+117,092
| +104% | +$1.37M | ﹤0.01% | 2663 |
|
|
2016
Q1 | $1.15M | Buy |
112,208
+2,310
| +2% | +$32.8K | ﹤0.01% | 3208 |
|
|
2015
Q4 | $1.97M | Buy |
109,898
+79,659
| +263% | +$1.47M | ﹤0.01% | 3072 |
|
|
2015
Q3 | $674K | Buy |
+30,239
| New | +$817K | ﹤0.01% | 3420 |
|
Other funds holding TDOC
VPM
VCM
VC
Northern Trust's TDOC Position: Q1 2026 in Review
Northern Trust increased its Teladoc Health (TDOC) stake by 4.3% in Q1 2026, buying an estimated $413K and bringing the position to 1,801,200 shares worth $9.82M. The position accounts for ﹤0.01% of the portfolio, ranked #2092.
Northern Trust first reported a position in TDOC in Q3 2015 and has held it in 43 quarters since. The position peaked at $158M in Q4 2020. 322 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.
- Northern Trust held 1,801,200 shares of Teladoc Health worth $9.82M as of Q1 2026.
- Northern Trust bought 73,691 Teladoc Health shares in Q1 2026, an estimated $413K.
- Teladoc Health made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #2092 holding.
- Northern Trust first reported a position in Teladoc Health in Q3 2015 and has held it in 43 quarters since.
- Northern Trust's Teladoc Health position peaked at $158M in Q4 2020.
- 322 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.